Cargando…
2194. Procalcitonin-Guided Antibiotic Strategy for Lower Respiratory Tract Infections: Outcomes and Safety of Withholding Antibiotics
BACKGROUND: Procalcitonin (PCT) is a promising and well-studied marker in differentiating viral from bacterial lower respiratory tract infections (LRTI). Antibiotics are not recommended when PCT is normal (< 0.25 μg/L). Despite this, it has not been the standard of care due to safety concerns of...
Autores principales: | Bambino Geno Tai, Don, Goldstein, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810131/ http://dx.doi.org/10.1093/ofid/ofz360.1874 |
Ejemplares similares
-
Efficacy and Safety of Procalcitonin-Guided Antibiotic Therapy in Lower Respiratory Tract Infections
por: Drozdov, Daniel, et al.
Publicado: (2013) -
The role of procalcitonin as a guide for the diagnosis, prognosis, and decision of antibiotic therapy for lower respiratory tract infections
por: El-Azeem, Amal Abd, et al.
Publicado: (2013) -
1968. Procalcitonin-Guided Antibiotic Therapy for Lower Respiratory Tract Infections in a US Academic Medical Center
por: Townsend, Jennifer, et al.
Publicado: (2018) -
Design and rationale of the Procalcitonin Antibiotic Consensus Trial (ProACT), a multicenter randomized trial of procalcitonin antibiotic guidance in lower respiratory tract infection
por: Huang, David T., et al.
Publicado: (2017) -
Safety and tolerability of liquid amikacin in antibiotic-loaded bone cement – a case series
por: Tai, Don Bambino Geno, et al.
Publicado: (2021)